English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

It is generally accepted that hypertension and pro- arises whether, in analogy to the message from the teinuria are the two most important progression factors ELITE study, Ang II receptor blockers are superior to in chronic renal failure [1]. Antihypertensive drugs ACE inhibitors in renal failure as well. Some points slow progression, and this has been attributed mainly relating to these issues will be discussed here. to their blood-pressure-lowering eVect. It is generally agreed, however, that in various types of chronic renal failure [2‐4] angiotensin-converting enzyme (ACE) Sympathetic control of heart and kidney

Advantages of Ang II receptor blockade over ACE inhibition with respect to suppression of sympathetic activity: heartening news for the kidney?